119 results on '"Le Gal G."'
Search Results
2. Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR)
3. Diagnosis and management of heparin-induced thrombocytopenia
4. Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
5. Diagnostic de l’embolie pulmonaire
6. Gestion des agents antiplaquettaires en cas de procédure invasive non programmée ou d’hémorragie. Propositions du Groupe d’intérêt en hémostase périopératoire (GIHP) et du Groupe français d’études sur l’hémostase et la thrombose (GFHT) en collaboration avec la Société française d’anesthésie et de réanimation (SFAR)
7. Targeted sequencing to identify novel genetic risk factors for deep vein thrombosis: a study of 734 genes
8. Management of antiplatelet therapy in patients undergoing elective invasive procedures. Proposals from the French Working Group on perioperative haemostasis (GIHP) and the French Study Group on thrombosis and haemostasis (GFHT). In collaboration with the French Society for Anaesthesia and Intensive Care Medicine (SFAR)
9. Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR)
10. Assessing clinical probability of pulmonary embolism: prospective validation of the simplified Geneva score
11. Safety of multidetector computed tomography pulmonary angiography to exclude pulmonary embolism in patients with a likely pretest clinical probability
12. Diagnosis of acute pulmonary embolism
13. Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease
14. Net clinical benefit of hospitalization versus outpatient management of patients with acute pulmonary embolism
15. Scintigraphie pulmonaire pour suspicion d’embolie pulmonaire aiguë : état des lieux des pratiques en France en 2014
16. Evaluation of quantitative PCR for early diagnosis of Pseudomonas aeruginosa infection in cystic fibrosis: a prospective cohort study
17. Diagnostic characteristics of lower limb venous compression ultrasonography in suspected pulmonary embolism: a meta‐analysis
18. PB1530 Diagnostic Strategies in Postpartum Individuals with Suspected Venous Thromboembolism: A Scoping Review
19. PB1006 Accuracy and Interrater Agreement of Death Event Adjudications by Physician Trainees: Validation of the ISTH Definition of Pulmonary Embolism-Related Death in an Autopsy Cohort
20. PB1008 The Diagnostic Performance of the YEARS and PEGeD Algorithm in Patients with Prior Venous Thrombosis Suspected of Pulmonary Embolism
21. PB0486 Effect of Age on Risk for Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis
22. Prothrombin G20210A Mutation and Lower Extremity Peripheral Arterial Disease: A Systematic Review and Meta-analysis
23. Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis
24. Controversies in the diagnosis of venous thromboembolism
25. Stratégies diagnostiques devant une suspicion d’embolie pulmonaire aiguë : place actuelle et perspectives de la scintigraphie pulmonaire de ventilation–perfusion
26. Rentabilité diagnostique de l’échographie cardiaque transthoracique, transœsophagienne et du Holter ECG réalisés à titre systématique lors du bilan étiologique d’un premier accident vasculaire cérébral ischémique. Étude rétrospective de 220 patients
27. The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus
28. P4.07G.05 Prediction of Quality-of-Life Results after Lung Stereotactic Body Radiotherapy Using Functional Mapping on Gallium-68 Perfusion PET/CT
29. Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency
30. Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis
31. Risk of post‐thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study
32. Symptomatic subsegmental pulmonary embolism: what is the next step?
33. Performance of age‐adjusted D‐dimer cut‐off to rule out pulmonary embolism
34. Comparison of the Villalta post‐thrombotic syndrome score in the ipsilateral vs. contralateral leg after a first unprovoked deep vein thrombosis
35. Is atrial fibrillation associated with pulmonary embolism?
36. Validation d’un score de probabilité clinique de thrombose veineuse profonde des membres inférieurs spécifique à la médecine générale
37. Thrombocytopenia with and without thrombosis following COVID-19 vaccination: long-term management
38. Baseline imaging after therapy for unprovoked venous thromboembolism: a randomized controlled comparison of baseline imaging for diagnosis of suspected recurrence
39. Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta‐analysis
40. Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study
41. Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta‐analysis
42. The pulmonary embolism rule‐out criteria (PERC) rule does not safely exclude pulmonary embolism
43. Place actuelle et perspectives de la médecine nucléaire pour le diagnostic d’embolie pulmonaire aiguë
44. Safety of outpatient treatment in acute pulmonary embolism
45. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism
46. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta‐analysis of the management outcome studies
47. Clinical prediction rules for pulmonary embolism: a systematic review and meta-analysis
48. Differences in clinical presentation of pulmonary embolism in women and men
49. Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
50. Volumetric or time‐based capnography for excluding pulmonary embolism in outpatients?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.